Posted by Michael Wonder on 17 Jan 2024
PBAC - 2023 in review
18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS.
All up 13 new medicines were listed on the PBS last year; three of the 13 are new cancer medicines.
- January - Faricimab (Vabsymo)
- February - Opicapone (Omontys)
- March - NIL
- April - NIL
- May - Asciminib hydrochloride (Scemblix), Vosiritide (Voxzogo)
- June - NIL
- July - Avatrombopag maleate (Doptelet), Finerenone (Kerendia)
- August - Eptinezumab (Vyepti), Trabectedin (Yondelis)
- September - Patiromer sorbitex calcium (Veltassa)
- October - Bimekizumab (Bimzelx), Deucravacitinib (Sotyktu), Enfortumab vedotin (Padcev)
- November - Trastuzumab deruxtecan (Enhertu)
Posted by:
Michael Wonder